"Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release. 1997

S Ashraf, and Y Tian, and D Cowan, and U Nair, and R Chatrath, and N R Saunders, and K G Watterson, and P G Martin
Cardiothoracic Department, Killingbeck Hospital, Leeds, United Kingdom.

BACKGROUND Cytokines are implicated in the pathogenesis of the "whole-body inflammatory response" that may complicate the period after cardiopulmonary bypass (CPB). Low-Dose aprotinin in the pump during CPB has been shown to improve postoperative hemostasis and platelet preservation. We tested the hypothesis that low-dose aprotinin influences the inflammatory reaction (in terms of cytokine release) after CPB. METHODS In a prospective, randomized study, 36 patients undergoing elective coronary artery bypass grafting were investigated. Nineteen patients received low-dose aprotinin (2 x 10(6) KIU (280 mg] in the pump), and a control group of 19 did not. Complement activation, cytokine production, leukocyte elastase release. D-dimer level, full blood count, postoperative blood loss, and transfusion requirements were analyzed before, during, and after after CPB. RESULTS Interleukin-1 beta was not detected in either group, whereas traces of tumor necrosis factor-alpha were infrequently observed. Plasma elastase, interleukin-6, interleukin-8, and neutrophil count increased (p < 0.001) during and after CPB compared with the baseline levels, reaching a peak at 2 hours after protamine administration in both groups before returning toward baseline at 24 hours. Proinflammatory cytokine markers did not differ significantly (p > 0.1) between the groups throughout the study period. The C5b-9 level increased (p < 0.001) in both groups perioperatively, reaching its peak 15 minutes after protamine. Twenty-four-hour postoperative blood loss was significantly (p < 0.001) reduced in the aprotinin group in association with markedly reduced D-dimer levels (p < 0.001). Patients in the aprotinin group also received significantly less banked blood postoperatively than the control group (p < 0.01). CONCLUSIONS Low-dose aprotinin fails to modify proinflammatory cytokine release, yet confers hemostatic improvement through reduced fibrinolysis in patients undergoing routine coronary artery bypass grafting.

UI MeSH Term Description Entries
D007611 Aprotinin A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) BPTI, Basic Pancreatic Trypsin Inhibitor,Basic Pancreatic Trypsin Inhibitor,Bovine Kunitz Pancreatic Trypsin Inhibitor,Kallikrein-Trypsin Inactivator,Kunitz Pancreatic Trypsin Inhibitor,Trypsin Inhibitor, Basic, Pancreatic,Trypsin Inhibitor, Kunitz, Pancreatic,Antilysin,Bovine Pancreatic Trypsin Inhibitor,Contrical,Contrykal,Dilmintal,Iniprol,Kontrikal,Kontrykal,Pulmin,Traskolan,Trasylol,Zymofren,Inactivator, Kallikrein-Trypsin,Kallikrein Trypsin Inactivator
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases
D006490 Hemostatics Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. Antihemorrhagic,Hemostatic,Antihemorrhagics
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Ashraf, and Y Tian, and D Cowan, and U Nair, and R Chatrath, and N R Saunders, and K G Watterson, and P G Martin
August 1996, The Journal of thoracic and cardiovascular surgery,
S Ashraf, and Y Tian, and D Cowan, and U Nair, and R Chatrath, and N R Saunders, and K G Watterson, and P G Martin
February 2001, Scandinavian cardiovascular journal : SCJ,
S Ashraf, and Y Tian, and D Cowan, and U Nair, and R Chatrath, and N R Saunders, and K G Watterson, and P G Martin
February 2009, Anesthesia and analgesia,
S Ashraf, and Y Tian, and D Cowan, and U Nair, and R Chatrath, and N R Saunders, and K G Watterson, and P G Martin
June 1997, Anesthesia and analgesia,
S Ashraf, and Y Tian, and D Cowan, and U Nair, and R Chatrath, and N R Saunders, and K G Watterson, and P G Martin
April 2005, Journal of neurosurgery,
S Ashraf, and Y Tian, and D Cowan, and U Nair, and R Chatrath, and N R Saunders, and K G Watterson, and P G Martin
January 1998, The Annals of thoracic surgery,
S Ashraf, and Y Tian, and D Cowan, and U Nair, and R Chatrath, and N R Saunders, and K G Watterson, and P G Martin
September 2016, The Journal of allergy and clinical immunology,
S Ashraf, and Y Tian, and D Cowan, and U Nair, and R Chatrath, and N R Saunders, and K G Watterson, and P G Martin
January 2000, Le Journal medical libanais. The Lebanese medical journal,
S Ashraf, and Y Tian, and D Cowan, and U Nair, and R Chatrath, and N R Saunders, and K G Watterson, and P G Martin
April 2000, The Annals of thoracic surgery,
S Ashraf, and Y Tian, and D Cowan, and U Nair, and R Chatrath, and N R Saunders, and K G Watterson, and P G Martin
January 1993, Anesteziologiia i reanimatologiia,
Copied contents to your clipboard!